GB1129393A - Tetrazolyl alkanoic acids - Google Patents
Tetrazolyl alkanoic acidsInfo
- Publication number
- GB1129393A GB1129393A GB54597/66A GB5459766A GB1129393A GB 1129393 A GB1129393 A GB 1129393A GB 54597/66 A GB54597/66 A GB 54597/66A GB 5459766 A GB5459766 A GB 5459766A GB 1129393 A GB1129393 A GB 1129393A
- Authority
- GB
- United Kingdom
- Prior art keywords
- halo
- phenyl
- substituted
- tetrazolyl
- furyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F23—COMBUSTION APPARATUS; COMBUSTION PROCESSES
- F23K—FEEDING FUEL TO COMBUSTION APPARATUS
- F23K3/00—Feeding or distributing of lump or pulverulent fuel to combustion apparatus
- F23K3/10—Under-feed arrangements
- F23K3/14—Under-feed arrangements feeding by screw
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Combustion & Propulsion (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1,129,393. Tetrazolylalkanoic acids. MILES LABORATORIES Inc. 6 Dec., 1966 [13 Dec., 1985], No. 54597/66. Heading C2C. Novel tetrazolyl alkanoic acids (and soluble salts thereof ) which are useful as anti-inflammatory agents and have the general formula wherein R 1 is an aryl or heterocyclic aryl radical, e.g. phenyl, halo- or alkoxy-substituted phenyl, furyl, pyridyl or thienyl, R 2 is hydrogen or an aryl or heterocyclic aryl radical, e.g. phenyl, halo- or alkoxy-substituted phenyl, furyl, pyridyl or thienyl, R 3 is hydrogen or an alkyl, aryl or heterocyclic aryl radical, e.g. phenyl, halo- or alkoxy-substituted. phenyl, furyl, pyridyl or thienyl, m is 0, 1 or 2 and n is 0, 1, 2 or 3, are prepared by the base catalysed alkylation of the corresponding 5-substituted tetrazole using as alkylating agent a compound which will substitute the tetrazole at the 2-position with the odesired carbolix acid side chain or a precursor thereof. Alkylating agents include halo esters and halo nitriles, necessitating hydrolysis as the final step in the preparation, and #-propiolactone is used in the synthesis of tetrazolyl propionic acids. Sodium and potassium salts and several intermediate ethyl esters (obtained by the interaction of the appropriate 5-substituted-tetrazole and an ethyl ester, of a #-halo-acid in the presence of sodium ethoxide) of the tetrazolyl alkanoic acids are described and characterized.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51359965A | 1965-12-13 | 1965-12-13 | |
US513553A US3412193A (en) | 1965-12-13 | 1965-12-13 | 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1129393A true GB1129393A (en) | 1968-10-02 |
Family
ID=27057915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB54597/66A Expired GB1129393A (en) | 1965-12-13 | 1966-12-06 | Tetrazolyl alkanoic acids |
Country Status (7)
Country | Link |
---|---|
US (1) | US3412193A (en) |
BE (1) | BE691049A (en) |
CH (1) | CH476001A (en) |
DE (1) | DE1620057C3 (en) |
FR (1) | FR1504326A (en) |
GB (1) | GB1129393A (en) |
NL (1) | NL6617500A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007502817A (en) * | 2003-08-20 | 2007-02-15 | イーライ リリー アンド カンパニー | Compounds, methods and formulations for oral delivery of glucagon-like peptide (GLP) -1 compounds or melanocortin 4 receptor (MC4) agonist peptides |
US8552039B2 (en) | 2003-08-20 | 2013-10-08 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL140242B (en) * | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | METHOD FOR PREPARING THE 11-PLACE SUBSTITUTED DIBENZ (B.F.) (1.4) OXAZEPINES BY A BASIC GROUP. |
GB1192812A (en) * | 1966-05-20 | 1970-05-20 | American Cyanamid Co | 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts |
US3597429A (en) * | 1968-02-15 | 1971-08-03 | Miles Lab | Derivatives of tetrazolyl alkanoic acids |
GB1265866A (en) * | 1968-08-23 | 1972-03-08 | ||
US3884922A (en) * | 1969-07-31 | 1975-05-20 | Yoshitomi Pharmaceutical | 11-(4-Pyridylalkyl-piperazino)-dibenzothiazepines |
US4049809A (en) * | 1976-11-24 | 1977-09-20 | American Cyanamid Company | Solution of a oxazepine for oral or parenteral administration |
GB1587128A (en) * | 1977-04-07 | 1981-04-01 | Hexachimie | Benzothiazepine derivatives |
US5223497A (en) * | 1989-03-31 | 1993-06-29 | Yale University | Treating habit disorders |
US5114942A (en) * | 1989-03-31 | 1992-05-19 | Yale University | Treating habit disorders |
US5059600A (en) * | 1989-03-31 | 1991-10-22 | Yale University | Treating habit disorders |
JP2002508323A (en) * | 1997-12-17 | 2002-03-19 | メルク エンド カムパニー インコーポレーテッド | Integrin receptor antagonist |
US6890919B2 (en) * | 2001-06-26 | 2005-05-10 | Shitij Kapur | Atypical antipsychotic agents having low affinity for the D2 receptor |
US7388954B2 (en) * | 2002-06-24 | 2008-06-17 | Freescale Semiconductor, Inc. | Method and apparatus for tone indication |
AU2003290079A1 (en) * | 2002-12-20 | 2004-07-14 | Basf Aktiengesellschaft | Pesticidal dibenzo(hetero)azepine derivatives |
JP2006515628A (en) * | 2003-01-23 | 2006-06-01 | アカディア ファーマシューティカルズ,インコーポレーテッド | Use of N-desmethylclozapine to treat human neuropsychiatric disorders |
US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
MXPA06007244A (en) | 2003-12-22 | 2006-08-18 | Acadia Pharm Inc | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders. |
BRPI0509524A (en) * | 2004-04-01 | 2007-09-18 | Acadia Pharm Inc | crystalline forms of n-desmethylclozapine |
WO2007053618A1 (en) * | 2005-10-31 | 2007-05-10 | Acadia Pharmaceuticals Inc. | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
WO2009154563A1 (en) | 2008-06-20 | 2009-12-23 | Astrazeneca Ab | Dibenzothiazepine derivatives and use thereof |
-
1965
- 1965-12-13 US US513553A patent/US3412193A/en not_active Expired - Lifetime
-
1966
- 1966-12-06 GB GB54597/66A patent/GB1129393A/en not_active Expired
- 1966-12-12 BE BE691049D patent/BE691049A/xx unknown
- 1966-12-12 FR FR87038A patent/FR1504326A/en not_active Expired
- 1966-12-12 DE DE1620057A patent/DE1620057C3/en not_active Expired
- 1966-12-13 NL NL6617500A patent/NL6617500A/xx unknown
- 1966-12-13 CH CH1779166A patent/CH476001A/en not_active IP Right Cessation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007502817A (en) * | 2003-08-20 | 2007-02-15 | イーライ リリー アンド カンパニー | Compounds, methods and formulations for oral delivery of glucagon-like peptide (GLP) -1 compounds or melanocortin 4 receptor (MC4) agonist peptides |
US7947841B2 (en) | 2003-08-20 | 2011-05-24 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide |
JP4754487B2 (en) * | 2003-08-20 | 2011-08-24 | エミスフィアー テクノロジーズ インコーポレイテッド | Compounds, methods and formulations for oral delivery of glucagon-like peptide (GLP) -1 compounds or melanocortin 4 receptor (MC4) agonist peptides |
US8546581B2 (en) | 2003-08-20 | 2013-10-01 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide |
US8552039B2 (en) | 2003-08-20 | 2013-10-08 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
US8765796B2 (en) | 2003-08-20 | 2014-07-01 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
Also Published As
Publication number | Publication date |
---|---|
FR1504326A (en) | 1967-12-01 |
BE691049A (en) | 1967-05-16 |
US3412193A (en) | 1968-11-19 |
DE1620057A1 (en) | 1970-03-19 |
NL6617500A (en) | 1967-06-14 |
DE1620057B2 (en) | 1977-10-06 |
DE1620057C3 (en) | 1978-06-08 |
CH476001A (en) | 1969-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1129393A (en) | Tetrazolyl alkanoic acids | |
SE7613651L (en) | WAY TO PREPARE PHENYLETIC ACID DERIVATIVES | |
GB1456221A (en) | 3-hydroxy cephalosporins their ether derivatives and methods for their preparation | |
GB1396286A (en) | Herbicidal compounds | |
ES397308A1 (en) | Esters of mandeloylaminocephalosporanic acids | |
ES368534A1 (en) | 4 5-dihydrothieno(2 3-b)(1)benzothiepin derivatives as cns depressants | |
GR37361B (en) | METHOD FOR THE MANUFACTURE OF DIARYLOCYCLOPROPANE PRODUCERS. | |
GB1290841A (en) | ||
FR2367045A1 (en) | PREPARATION OF ALIPHATIC AND HETEROCYCLIC A-CETOCARBOXYLIC ACIDS | |
GB1438419A (en) | 2-oxo-1-pyridinyl penicillin and cephalosporin derivatives | |
GB1138587A (en) | Improvements in or relating to photographic material | |
ES369174A1 (en) | 5-(2-(phenylamino)-3-pyridyl)tetrazoles substituted in the phenyl nucleus | |
JPS54112864A (en) | Novel imidazole derivative, its mineral acid salt, and their preparation | |
GB1434757A (en) | Method and composition for the control of fertility | |
ES385581A1 (en) | Preparation of 7-amino-cephalo-sporanic acid derivatives | |
GB1252109A (en) | ||
GB1284423A (en) | Cyclohexa-1,4-diene-1-acetic acids | |
GB1319402A (en) | 3-acyloxypropyl-2,-trimethylammoniumethyl phosphates | |
GB1341612A (en) | Theophylline isobutyrate salts and process for the preparation thereof | |
ES483699A1 (en) | New process for preparing an 1H-indazol-3-ylacetic acid derivative. | |
GB1266655A (en) | ||
ES377994A1 (en) | Procedure for the preparation of new derivatives of imidazolidinone. (Machine-translation by Google Translate, not legally binding) | |
ES420666A1 (en) | (1-methyl-5-nitro-2-imidazolyl)thioalkanoic acids and derivatives | |
GB1248472A (en) | Cycloheptimidazolone derivatives and process for the preparation thereof | |
GB1284019A (en) | Anticonvulsant compositions |